JP2021511379A5 - - Google Patents
Info
- Publication number
- JP2021511379A5 JP2021511379A5 JP2020560576A JP2020560576A JP2021511379A5 JP 2021511379 A5 JP2021511379 A5 JP 2021511379A5 JP 2020560576 A JP2020560576 A JP 2020560576A JP 2020560576 A JP2020560576 A JP 2020560576A JP 2021511379 A5 JP2021511379 A5 JP 2021511379A5
- Authority
- JP
- Japan
- Prior art keywords
- chondrodysplasia
- pharmaceutical composition
- fffr3
- composition according
- bone disease
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18305053 | 2018-01-24 | ||
| EP18305053.3 | 2018-01-24 | ||
| PCT/EP2019/051622 WO2019145356A1 (en) | 2018-01-24 | 2019-01-23 | Methods and pharmaceutical compositions for the treatment of fgfr3-related chondrodysplasias |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021511379A JP2021511379A (ja) | 2021-05-06 |
| JP2021511379A5 true JP2021511379A5 (https=) | 2022-01-17 |
| JPWO2019145356A5 JPWO2019145356A5 (https=) | 2022-01-17 |
| JP7286675B2 JP7286675B2 (ja) | 2023-06-05 |
Family
ID=61163620
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020560576A Active JP7286675B2 (ja) | 2018-01-24 | 2019-01-23 | Ｆｇｆｒ３関連軟骨異形成症の処置のための方法及び医薬組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US11951090B2 (https=) |
| EP (1) | EP3743062B1 (https=) |
| JP (1) | JP7286675B2 (https=) |
| ES (1) | ES2985639T3 (https=) |
| WO (1) | WO2019145356A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250041262A1 (en) * | 2021-12-16 | 2025-02-06 | Institut National de la Santé et de la Recherche Médicale | Compositions for the treatment of fgfr3-related cognitive deficits with a catechin |
| US20250041263A1 (en) * | 2021-12-20 | 2025-02-06 | Institut National de la Santé et de la Recherche Médicale | Use of catechin for the treatment of fgfr-related bone repair and bone formation impairment |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016046375A1 (en) | 2014-09-25 | 2016-03-31 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Theobroma cacao extract for use in the treatment or prevention of receptor tyrosine kinases related disorders |
-
2019
- 2019-01-23 ES ES19700956T patent/ES2985639T3/es active Active
- 2019-01-23 JP JP2020560576A patent/JP7286675B2/ja active Active
- 2019-01-23 WO PCT/EP2019/051622 patent/WO2019145356A1/en not_active Ceased
- 2019-01-23 US US16/964,781 patent/US11951090B2/en active Active
- 2019-01-23 EP EP19700956.6A patent/EP3743062B1/en active Active
-
2023
- 2023-09-08 US US18/463,707 patent/US12257232B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN114269746A (zh) | 一种螺芳环化合物、其制备及应用 | |
| JOP20210001A1 (ar) | مشتقات 3-(5- هيدروكسي -1- أوكسو أيزو إندولين -2- يل) بيبريدين -2، 6- دايون واستخدامها لمعالجة أمراض مرتبطة ببروتين ذات أصبع الزنك من عائلة (ikaros 2 (ikzf2 | |
| JP2018035160A5 (https=) | ||
| CU24671B1 (es) | Compuesto de pirimidina inhibidor de las janocinasas, composición, forma cristalina y proceso de preparación | |
| EA202090553A1 (ru) | Производные 3-(1-оксоизоиндолин-2-ил)пиперидин-2,6-диона и варианты их применения | |
| JP2020513804A5 (https=) | ||
| JP2017222697A5 (https=) | ||
| JP2010031025A5 (https=) | ||
| JP2021511379A5 (https=) | ||
| JP2016511753A5 (https=) | ||
| JP2014511374A5 (https=) | ||
| JP2012505891A5 (https=) | ||
| MX2021008002A (es) | Sales nuevas y forma polimorfica del acido bempedoico. | |
| JP2016510323A5 (https=) | ||
| JO2793B1 (en) | New Crystaline form V of Agomelatine, A process for It's Preparation and Pharmaceutical Compositions Containig it. | |
| JP2009531465A5 (https=) | ||
| JP2017506666A5 (https=) | ||
| CN103717571B8 (zh) | 9‑氨基甲基取代的四环素类化合物 | |
| JP2017508816A5 (https=) | ||
| JP2019504103A5 (https=) | ||
| JP2022502053A5 (https=) | ||
| MX2018001204A (es) | Metodo para preparar derivados de acido 3-(2-anilino-1-ciclohexil- 1h-bencimidazol-5-il)propanoico sustituido. | |
| IL313466B2 (en) | Inhibiting creb binding protein (cbp) | |
| BR112022007207A2 (pt) | Composição farmacêutica que compreende selexipag | |
| JP2018521056A5 (https=) |